Lynkuet Capsule
Product Images NDC 50419-475

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lynkuet (NDC 50419-475). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lynkuet 01)

FDA Label Image

Principal Display Panel (60 mg Capsule Blister Pack)

This is a description of a prescription medication called Lynkuet® capsules. Each capsule contains 60mg of the active ingredient, linzanetant. The medication is indicated for prescription use only. The NDC (national drug code) for this medication is 50419-475-01.*

FDA Label Image

Principal Display Panel (60 mg Capsule Blister Pack Carton)

This is a description of elinzanetant capsules that come in a carton containing 5 blister cards of 12 capsules each. The recommended dosage is detailed in the prescribing information, and the capsules should be stored between 20°C to 25°C. The capsules should be kept out of reach of children and stored between 15 to 30°C. For more information, one can call 1-888-842-2937 or visit the website www.LYNKUET.com. The capsules are distributed by Bayer HealthCare Pharmaceuticals Inc. and manufactured in Germany.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.